Cargando…
Perioperative diltiazem therapy was not associated with improved perioperative and long-term outcomes in patients undergoing on-pump coronary artery bypass grafting
BACKGROUND: Diltiazem has been used during the perioperative period in patients undergoing coronary artery bypass grafting (CABG) to prevent arterial graft spasm. However, its long-term outcome effects remain unclear. METHODS: Patient records obtained from the Society of Thoracic Surgeons and the Ge...
Autores principales: | Zhang, Xiaopeng, Hu, Yirui, Friscia, Michael E., Wu, Xianren, Zhang, Li, Casale, Alfred S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430801/ https://www.ncbi.nlm.nih.gov/pubmed/37588585 http://dx.doi.org/10.1016/j.bjao.2022.100025 |
Ejemplares similares
-
Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: A systematic review and network meta-analysis
por: Hu, Yirui, et al.
Publicado: (2018) -
Perioperative aspirin and long-term survival in patients undergoing coronary artery bypass graft
por: Ding, Qian, et al.
Publicado: (2018) -
Perioperative covert stroke in patients undergoing coronary artery bypass graft surgery
por: Browne, Austin, et al.
Publicado: (2020) -
Perioperative coronary artery spasm after off-pump coronary artery bypass grafting in the non-manipulated coronary artery
por: Bai, Yunpeng, et al.
Publicado: (2022) -
MiR-223 levels predicting perioperative bleeding in off-pump coronary artery bypass grafting
por: Wang, Zi, et al.
Publicado: (2020)